Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
COVID hospitalizations were down to approximately 1,000 per day back in July, just like I estimated. I'll go on the record again and say COVID hospitalizations will again be down to approximately 1,000 per day (or less) before July 2022.
The FDA doesn't have enough information (which is obvious since HGEN's data hasn't even been peer reviewed --- I wonder why?) and the data they do have ain't so great. Thus, data mining by Management regarding the Black community and the trial changes in the current study.
It is if you're vaccinated and the % of those vaccinated has hit my previous estimates. I expect those getting vaccinated will continue to increase as companies require their workers or like Delta punish their workers for not getting vaccinated.
There is no way they are selling Lenz for $10K per treatment. Foreign countries aren't going to pay more than 25% of that.
(1) Millions of treatments are not and will not be needed. (2) HGEN would need to spend $500+ million to get production anywhere near a million treatments...and that ain't never gonna happen.
Funny stuff, Jay. An increase in projected revenues? Try again... There was no increase but just moving previously projected revenues that were supposed to occur in FY 2021 to FY 2022. Clearly, these analysts have no clue what they're doing --- just throwing spaghetti on the wall and hoping it sticks. But, glad to see you all have analysts on your pro's list. Funny stuff...
There you go again... $20-100 billion in revenues. (1) You failed to update your revenue forecast to cover only the Black community. (2) HGEN may have 100K treatments available by year-end 2021 and that's only if they get approval by September 30 so they keep production going. But, good to know you have 2-10 million treatments in your estimate. Now that's some LMAO, funny stuff.
True... Except this is EUA and the longer the review goes, the less likely authorization will be granted. The FDA is at 88 days and counting, clearly they don't see an urgency in approving Lenz for "Emergency" use.
Has anyone noticed that analysts have slashed their earnings estimates? I wonder why...
Love is helping people. And sadly, it's those who are vaccinated that are trying to help those who believe in utter non-sense. Kind of reminds of this message board. How come 99% of the people dying today from COVID haven't been vaccinated? Maybe there is a solution... Get vaccinated!!
All of my responses are straightforward. If I don't reply to your message it's most likely because I have you on mute. Life is too short to deal with complete non-sense.
No value? Pretty sure you wouldn't have negative HGEN returns this year had you listened. What was condescending?
What is driving the share price lower? Management burning through $100+ million a quarter, Dale selling shares at $17, ATM dilution, EUA isn't coming, or all of the above.
HUGE?! What is huge about an ATM? Any company issue shares via an ATM... There is no special approval needed to sell more shares.
You fail to consider HGEN will burn through $100+ million in Q3 2021 and thus, they need to issue more shares to have any reasonable cash position heading into Q4.
Management loves longs that don't mind being bagholders. Enjoy the dilution!!
Because the easy money was made and very quickly. Shorting is just a trade not an investment. I'll be happy to go short again, however, there's too many people who believe in the long side to short at current levels.
See my prior post. BTW, you do realize Dale isn't on Etrade or Robinhood selling his shares, right? If the investment house managing the position could have sold for $18+ vs. $17 and change they would have.
"His Situation"... Yeah. Something like that. Maybe you should spend some time doing some research on this topic.
You act like if Dale could sell every share tomorrow he wouldn't. Nobody on this board appears to understand the game. Biotech executives have been doing this for decades and decades... If Dale sold all of his shares being "Chief Scientific Officer", HGEN's share price would crater because who would buy its shares except for those on this board. So, like any good Ponzi scheme its a long game... Sell 1% of your holdings every couple of weeks, give yourself some more stock options and talk about all the great work you're doing while you sell your shares to new shareholders. And because you're a biotech, you dilute your existing shareholder base at the same time because you need to investment significantly in this "breakthrough" idea in some multi-billion dollar market.
Thank you for the long winded reply. You know you could have just said you were right 10nisman.
Right... It means nothing.
It's amazing how people rationalize everything they do no matter how less than ideal their actions. From not getting vaccinated or wearing a mask to trying to convince themselves they are holding shares of some great company. Everybody wants to believe Management, yet their actions say the exact opposite. If Dale thought this was going to $50 or $100 or $500 where most of you had your expectations, he wouldn't be selling shares at $17 no matter what price he bought them at. So, Dale's selling and you all are buying...
Enjoy your shares longs, Dale thanks you for your devotion...
Selling shares reinforces the thesis that EUA is eminent?! Haha...That is comical. Actually, selling shares means HGEN is going to burn through another $100+ million in cash this quarter and needs someone to foot the bill. Sadly, in 48 days production will be shuttered and longs will just be bagholders. Nothing like getting diluted to produce product that will never be sold... Even worse, is HGEN will need to do another financing next quarter when Lenz doesn't receive EUA as HGEN will have burned through its cash.
Yes... Couldn't agree more. Everyone thinks SPAC's are this new thing and they've been around for about 30 years and in other forms for much and much longer.
So, not only is HGEN going to burn through another $100 million this quarter but its going to shutdown production in 49 days without approval. HGEN will be trading in the mid single digits in a couple months if they don't get approval. But, keep pumping away while Management keeps dumping.
BlackRock doesn't do deals --- they are an investment manager managing one of the largest ETF brands in the world (iShares). And their increased share position is the result of its ETF's tracking an index vs. taking some corporate share position in HGEN.
Because BlackRock's iShares ETF's have to track their underlying indices which results in some of the ETF's having to own HGEN. It's very sad people actually think BlackRock is adding shares of HGEN for its own interest.
No F'ing way. Private equity platforms being privately held with no public issues (equity price volatility, quarterly filings, etc.) and other public non-sense is vital to its value creation. Anyone that believes this non-sense is out to lunch.